This compound is primarily utilized in peptide synthesis, particularly in solid-phase peptide synthesis (SPPS) methods. Its structure incorporates a pseudoproline dipeptide, specifically the Phe-Ser(Psi(Me,Me)Pro) unit, which helps in reducing secondary structure formation during peptide chain assembly. This property enhances the efficiency of synthesizing long or complex peptides by minimizing aggregation and improving solubility. It is especially valuable in the production of peptides with challenging sequences, where traditional methods may lead to incomplete reactions or low yields. The Fmoc group provides protection for the amino terminus during synthesis, allowing for selective deprotection and elongation of the peptide chain. This chemical is widely used in research and pharmaceutical development for creating bioactive peptides, peptidomimetics, and other peptide-based therapeutics.